U.S. biotech firm files for Chapter 11 bankruptcy | Milwaukee, WI

BREAKING NEWS:   U.S. Department of Justice announces new rules to discharging federal student loans. Find out if you qualify TODAY!

Milwaukee 414-250-7880         Madison 608-465-4594         Green Bay 920-626-3125

Serving all of Wisconsin
Toll-free 866-906-5634  Milwaukee  414-250-7880     Madison  608-465-4594     Green Bay 920-626-3125

Our 3 Step Process

Step 1:
Get Out Of Debt

Step 2:
Clean Up Your Credit

Step 3:
Build Your Score

Home 9 Debt Relief 9 U.S. biotech firm files for Chapter 11 bankruptcy

U.S. biotech firm files for Chapter 11 bankruptcy

by | Oct 17, 2013 | Debt Relief

Wisconsin residents might be interested to hear that the U.S. biotech firm, Savient Pharmaceuticals Inc. filed for Chapter 11 bankruptcy protection on Oct 14. The company filed for the protection in a Delaware court. The firm also said that it has agreed to sell most of its assets to Sloan Holdings CV for approximately $55 million.

According to the firm, the agreement with Sloan Holdings CV would serve as a ‘stalking horse bid” in an auction of the firm’s assets that would be supervised by the court. The stalking horse bid serves as the minimum bid for the business designed to help it obtain debt relief, and it could still be topped by other bids. The company has been under pressure from its largest creditor to liquidate its assets. However, it said that it would still keep its drug for gout, Krystexxa, commercially available in the United States.

As of June 30, the firm reported its assets to be approximately $74 million and its liabilities to be $260 million. Shares for the company closed at 57 cents on Oct. 14. They have fallen 47 percent this year. Krystexxa has reportedly had disappointing sales since it was launched back in September 2010. The drug is designed to treat patients diagnosed with gout who don’t respond well to conventional therapy.

Chapter 11 bankruptcy can serve as a form of debt protection for businesses without them having to file for complete bankruptcy. It helps them reorganize their debts and accept a payment plan to get them back on track. Bankruptcy attorneys might be able to assist business owners with filing for the appropriate type of bankruptcy. They might also be able to help them liquidate their assets and restructure their finances.

Source: Reuters, “Savient Pharmaceuticals files for Chapter 11 bankruptcy“, October 14, 2013


Complete this form to receive your FREE copy of Attorney Miller’s book, Back On Track – How Bankruptcy can Revert the Financial Impact of COVID-19. Order today to begin your personal journey toward true financial freedom.

Sidebar (Book Request)